News Releases
Search and Filter
Results per Page:
Fred Hutchinson Cancer Center receives $78 million gift to support precision oncology
The gift, from Stuart and Molly Sloan, is the largest in Fred Hutch history and will help fund a new research building on the Seattle campus
Seattle Cancer Care Alliance Physicians Named in Seattle Met’s 2022 “Top Doctors”
The newly integrated organization had over 40 physicians, physician assistants and nurse practitioners recognized in the 2022 list of top doctors
Dr. Anthony Fauci to receive honorary Hutch Award®
Director of the National Institute of Allergy and Infectious Diseases recognized for his lifetime of service to a healthier world
Fred Hutch Obliteride celebrates 10-year anniversary with over 3,800 participants expected
Fundraising bike ride, run and walk is back in person for the first time since 2019
Fred Hutch announces recipients of the 4th annual Dr. Eddie Méndez Award
Award honors postdoctoral researchers from underrepresented groups in science
Notice of a Data Security Incident Involving Seattle Cancer Care Alliance Patients
Currently no indication of any identity theft or fraud occurring as a result of this incident
Major study links breast cancer treatment with increased risk of cardiovascular disease
Researchers urge survivors and their doctors to monitor heart health
Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle Children’s and UW Medicine Complete Restructure of Partnership
Fred Hutchinson Cancer Center is a unified adult cancer research and care center that is a clinically integrated part of UW Medicine
Fred Hutch announces 2022 Harold M. Weintraub Graduate Student Award recipients
Thirteen graduate students selected for prestigious award in biological sciences
Tip Sheet: Fred Hutch experts tackle long COVID, improving outcomes for leukemia patients – and tips on staying healthy
Summaries of recent Fred Hutch research findings and other news
IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology
Phase 1 trial aims to build on response seen in proof-of-concept trial